In-hospital medication administration prior to in-hospital cardiac arrest: a matched case-control study.
6 affiliations
- 1Department of Anaesthesiology and Intensive Care, Aarhus University Hospital, Aarhus, Denmark.
- 2Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
- 3Department of Anaesthesiology and Intensive Care, Gødstrup Hospital, Herning, Denmark.
- 4Department of Cardiology, Horsens Hospital, Horsens, Denmark.
- 5Department of Clinical Pharmacology, Aarhus University Hospital, Aarhus, Denmark.
- 6Prehospital Emergency Medical Services, Central Denmark Region, Aarhus, Denmark.
Abstract
Background
Limited research has examined medication administration in patients with in-hospital cardiac arrest (IHCA). We aimed to identify and describe in-hospital medications administered 24 h prior to IHCA compared with matched controls.Methods
This study was a registry-based, matched, case-control study including patients who were hospitalized in the Central Denmark Region from 2017 to 2022. Patients with IHCA were matched with hospitalized controls on age, sex, length, and period of admission. The index time was defined as the time of IHCA for cases, and a corresponding index time was assigned to matched controls. Medication administrations within 24 h prior to index time were identified and divided into 21 groups based on ATC codes, e.g. QTc-prolonging drugs. New medication administrations were defined as no prior redeemed prescription for the same ATC code within 2 years.Results
A total of 1976 cases and 19,716 controls met the study criteria and were included in the study. Among cases, the most frequently administered medication groups were antithrombotic agents (43% of cases), antibiotics (42%), and diuretics (35%), whereas for controls the groups were antibiotics (33% of controls), antithrombotic agents (33%), and opioids (24%). Overall, cases were administered a median of 11 (IQR: 0-20) medications within 24 h prior to the index time as compared to 5 (IQR: 0-14) medications for controls.Conclusion
Medications administered in-hospital within 24 h prior to IHCA differed from those in matched controls and were characterized by a higher proportion of newly initiated treatments. These findings may help form new hypotheses on strategies on prevention of IHCA.
Related
- Antiseizure Medication Administration Gaps Across the ICU-to-Floor Transfer: A Matched Within-Patient Comparison
- Statistical process control within the Six Sigma DMAIC framework for monitoring medication dispensing errors in hospital pharmacies: a Saudi case study
- Risk factors for a low five-minute Apgar score at a provincial referral hospital in southern Mozambique: A secondary analysis of a matched case-control study
- Serum 25-hydroxyvitamin D levels and prevalent diabetic retinopathy in adults with type 2 diabetes: a retrospective hospital-based matched case-control study.
- Preoperative Antibiotic Administration Before Distal Radius Fracture ORIF and Postoperative Outcomes: A Propensity-Matched Cohort Study
BibTeX
@article{hansen2026inhospital,
title = {{In-hospital medication administration prior to in-hospital cardiac arrest: a matched case-control study.}},
author = {Stine H Hansen and Peter C Lind and Frederik G Hansen and Nikola Stankovic and Mathias J Holmberg and Lars W Andersen and Asger Granfeldt},
journal = {Resuscitation plus},
year = {2026},
month = oct,
doi = {10.1016/j.resplu.2026.101511},
url = {https://europepmc.org/article/MED/42927132},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - In-hospital medication administration prior to in-hospital cardiac arrest: a matched case-control study.
AU - Stine H Hansen
AU - Peter C Lind
AU - Frederik G Hansen
AU - Nikola Stankovic
AU - Mathias J Holmberg
AU - Lars W Andersen
AU - Asger Granfeldt
PY - 2026
DA - 2026/10/05
JO - Resuscitation plus
DO - 10.1016/j.resplu.2026.101511
UR - https://europepmc.org/article/MED/42927132
AB - Background Limited research has examined medication administration in patients with in-hospital cardiac arrest (IHCA). We aimed to identify and describe in-hospital medications administered 24 h prior to IHCA compared with matched controls.Methods This study was a registry-based, matched, case-control study including patients who were hospitalized in the Central Denmark Region from 2017 to 2022. Patients with IHCA were matched with hospitalized controls on age, sex, length, and period of admission. The index time was defined as the time of IHCA for cases, and a corresponding index time was assigned to matched controls. Medication administrations within 24 h prior to index time were identified and divided into 21 groups based on ATC codes, e.g. QTc-prolonging drugs. New medication administrations were defined as no prior redeemed prescription for the same ATC code within 2 years.Results A total of 1976 cases and 19,716 controls met the study criteria and were included in the study. Among cases, the most frequently administered medication groups were antithrombotic agents (43% of cases), antibiotics (42%), and diuretics (35%), whereas for controls the groups were antibiotics (33% of controls), antithrombotic agents (33%), and opioids (24%). Overall, cases were administered a median of 11 (IQR: 0-20) medications within 24 h prior to the index time as compared to 5 (IQR: 0-14) medications for controls.Conclusion Medications administered in-hospital within 24 h prior to IHCA differed from those in matched controls and were characterized by a higher proportion of newly initiated treatments. These findings may help form new hypotheses on strategies on prevention of IHCA.
SN - 2666-5204
ER -